Search research articles
Contact Us
Filters
Showing results (71-80 of 510) with videos related to
Page
of 51
Sort By:
BMC Health Services Research
|
October 18, 2023
Estimated indirect costs of haemodialysis versus peritoneal dialysis from a patients' perspective at an Academic Hospital in Pretoria, South Africa
Kotulo Moalosi, Mncengeli Sibanda, Amanj Kurdi, et al.
Applied Health Economics and Health Policy
|
October 6, 2009
Soft regulations in pharmaceutical policy making: an overview of current approaches and their consequences
Björn Wettermark, Brian Godman, Bengt Jacobsson, et al.
BMC Health Services Research
|
September 12, 2015
The impact of the 'Better Care Better Value' prescribing policy on the utilisation of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for treating hypertension in the UK primary care setting: longitudinal quasi-experimental design
Amanj Baker, Li-Chia Chen, Rachel A Elliott, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
September 24, 2015
The impact of South Korea's new drug-pricing policy on market competition among off-patent drugs
Hye-Young Kwon, Hyungmin Kim, Brian Godman, et al.
Expert Review of Clinical Pharmacology
|
August 5, 2017
Structure and activities of pharmacy and therapeutics committees among public hospitals in South Africa; findings and implications
Moliehi Matlala, Andries Gs Gous, Brian Godman, et al.
Vojnosanitetski Pregled
|
January 18, 2018
Consumption of antihistamines in Serbia in the period 2011-2015 and the correlation with adverse drug reaction reports
Vesela Radonjić, Ivana Jović, Marija Kalaba, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
November 29, 2012
Ongoing initiatives in the Republic of Srpska to enhance prescribing efficiency: influence and future directions
Vanda Markovic-Pekovic, Ranko Skrbić, Brian Godman, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 13, 2009
Impact of recent reforms in Austria on utilization and expenditure of PPIs and lipid-lowering drugs: implications for the future
Brian Godman, Thomas Burkhardt, Anna Bucsics, et al.
Journal of Comparative Effectiveness Research
|
December 13, 2016
Adverse effects of carbamazepine monotherapy among patients in Nigeria: a pilot study and implications
Adedunni Olusanya, Olayinka Ogunleye, Brian Godman, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
December 21, 2012
Influence of lifting prescribing restrictions for losartan on subsequent sartan utilization patterns in Austria: implications for other countries
Anna Bucsics, Brian Godman, Thomas Burkhardt, et al.
Page
of 51
Search research articles
Search
Showing results (71-80 of 510) with videos related to
Sort By:
Page
of 51
BMC Health Services Research
|
October 18, 2023
Estimated indirect costs of haemodialysis versus peritoneal dialysis from a patients' perspective at an Academic Hospital in Pretoria, South Africa
Kotulo Moalosi, Mncengeli Sibanda, Amanj Kurdi, et al.
Applied Health Economics and Health Policy
|
October 6, 2009
Soft regulations in pharmaceutical policy making: an overview of current approaches and their consequences
Björn Wettermark, Brian Godman, Bengt Jacobsson, et al.
BMC Health Services Research
|
September 12, 2015
The impact of the 'Better Care Better Value' prescribing policy on the utilisation of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for treating hypertension in the UK primary care setting: longitudinal quasi-experimental design
Amanj Baker, Li-Chia Chen, Rachel A Elliott, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
September 24, 2015
The impact of South Korea's new drug-pricing policy on market competition among off-patent drugs
Hye-Young Kwon, Hyungmin Kim, Brian Godman, et al.
Expert Review of Clinical Pharmacology
|
August 5, 2017
Structure and activities of pharmacy and therapeutics committees among public hospitals in South Africa; findings and implications
Moliehi Matlala, Andries Gs Gous, Brian Godman, et al.
Vojnosanitetski Pregled
|
January 18, 2018
Consumption of antihistamines in Serbia in the period 2011-2015 and the correlation with adverse drug reaction reports
Vesela Radonjić, Ivana Jović, Marija Kalaba, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
November 29, 2012
Ongoing initiatives in the Republic of Srpska to enhance prescribing efficiency: influence and future directions
Vanda Markovic-Pekovic, Ranko Skrbić, Brian Godman, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 13, 2009
Impact of recent reforms in Austria on utilization and expenditure of PPIs and lipid-lowering drugs: implications for the future
Brian Godman, Thomas Burkhardt, Anna Bucsics, et al.
Journal of Comparative Effectiveness Research
|
December 13, 2016
Adverse effects of carbamazepine monotherapy among patients in Nigeria: a pilot study and implications
Adedunni Olusanya, Olayinka Ogunleye, Brian Godman, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
December 21, 2012
Influence of lifting prescribing restrictions for losartan on subsequent sartan utilization patterns in Austria: implications for other countries
Anna Bucsics, Brian Godman, Thomas Burkhardt, et al.
Page
of 51